ARUSHA, Tanzania — Tanzanian Pharmaceutical Industries
Limited announced that a new plant will
soon start production of anti-retrovira drugs (ARVs), East
African Business Week reported.
Production of the drugs is expected to start next month and
the plant will officially open on Dec. 1, World Aids Day.
The generic drug will cost local people living with HIV/Aids
about $12 for their monthly dosages.
target is to ensure that Tanzania and East African countries are self-sufficient
in the supply of the ARVs and other essential drugs in the region,” said Tanzanian
Pharmaceutical Industries Limited CEO Ramadhan Madabida.